Pfizer's trailing-12-month (TTM) revenue is $59.3 billion, whereas its TTM normalized diluted earnings per share (EPS) is ...

Issues with data quality, competing projects, and high-profile executive exits are allegedly all contributing to the slowdown ...

OpenAI’s efforts to develop its next major model, GPT-5, are running behind schedule, with results that don’t yet justify the ...

The startup has run into problem after problem on its new artificial-intelligence project, code-named Orion.